Bacterial Infections and Mycoses

318 trials 133 recruiting

Filter these 318 trials by phase, country and sponsor.

Open in Search →

ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I) Recruiting

2024-518607-21-00 Clostridioides difficile infection 4 2025-09-25
KISS Evaluation of early administration of Levetiracetam in the prevention and treatment of delirium during septic shock: a randomized, doub… Recruiting

2023-510449-51-00 Adult ICU patients with septic shock 5 2025-07-31
Clindamycin for the treatment of infections: the influence of rifampicin and obesity on PK/PD target attainment Recruiting

2024-515872-12-00 Hidradenitis suppurativa 6 2025-07-29
Phase IV, multicenter, single-arm clinical trial to evaluate the evolution of nail fungal infection in patients treated with DexULac Recruiting

2024-520381-62-00 onychomycosis 6 2025-07-03
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Sepsis 6 2025-07-01
A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dos… Recruiting

2024-514730-21-00 Bacterial infections and mycoses 5 2025-07-01
A Phase III study to evaluate the efficacy of INM004 (Shiga antitoxin) in pediatric patients with Shiga toxin-producing Escherichia coli-ass… Recruiting

2024-512412-22-00 Hemolytic Uremic Syndrome 5 2025-06-24
A first-in-human trial to evaluate safety, tolerability, and pharmacokinetics of single and multiple oral doses of Debio 1453P in healthy ad… Recruiting

2024-519328-26-01 Sexual Transmitted Infection (STI) 1 2025-06-18
Plasma and intraperitoneal pharmacokinetics of cefiderocol in peritoneal dialysis patients Recruiting

2024-518220-72-00 Patients undergoing peritoneal dialysis 3 2025-05-20
Randomized, Double Blind, Placebo Controlled "first-in-human" Study to Assess the Safety and Tolerability of Single Ascending Intravenous Do… Recruiting

2023-504324-26-00 Prevention of infections caused by Gram-negative bacter 1 2025-05-20
Development of an optimized dosing regimen of ceftazidime-avibactam in critically ill patients treated with continuous renal replacement the… Recruiting

2023-505536-35-00 Ceftazidime-avibactam therapy in critically ill patient 6 2025-05-04
Early Model-Informed Precision Dosing of beta-lactam antibiotics in critically ill children: big solution for small people? Recruiting

2024-516447-12-00 Systemic infections 6 2025-04-30
Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT) (REZAFECT) Recruiting

2024-519789-37-00 Invasive candidiasis 11 2025-04-16
The MIRAGE study. Use of radioactively labelled deferoxamine for a novel purpose: imaging pulmonary aspergillosis with PET/CT scans. Recruiting

2023-509744-10-00 Pulmonary aspergillosis 4 2025-04-01
Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot study (LANDCAP1) Recruiting

2024-511413-37-00 Community-acquired pneumonia 4 2025-03-03
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting

2024-515055-38-00 Adult patients undergoing TJR surgery. 5 2025-02-13
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study Recruiting

2024-519983-42-00 TUBERCULOSIS 4 2025-02-04
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Staphylococcus aureus bacteremia 6 2025-01-30
Fast-Track Therapeutic Model in Complicated Acute Appendicitis Recruiting

2025-520777-39-00 Complicated acute appendicitis 6 2025-01-29
Revised dosing of Ciprofloxacin for patients with impaired renal function: a bioequivalence study Recruiting

2024-520379-28-00 bacterial infection 6 2025-01-24
A study to assess how Vaborem® is taking up in the body and tolerated in paediatric patients with serious infections. Recruiting

2024-514656-32-00 Suspected or confirmed Gram negative infections 4 2025-01-23
A pilot study for optimizing meropenem administration in the intensive care unit – short six times vs. prolonged three times courses daily Recruiting

2024-520030-30-00 Serious infection requiring broad-spectrum antibiotic 5 2025-01-23
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Bacterial infection 6 2025-01-07
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03